Media Tool Kit

Find more information about the investor briefing and the press release issued at ASCO GI 2018.

Investor Briefing

Ipsen will be organizing an investor briefing with EXELIXIS at ASCO GI 2018 on January 19, 2018 at at 6:30 p.m. PST from the InterContinental San Francisco’s Grand Ballroom A (888 Howard St., San Francisco).

The event will also be webcast live. To access the webcast link, log onto www.exelixis.com and proceed to the News & Events / Event Calendar page under the Investors & Media heading.

For further other details or information, click on contact us

19th January
2018

EXELIXIS at ASCO GI 2018

InterContinental San Francisco’s Grand Ballroom A, 888 Howard St., San Francisco
register Register link Watch the webcast contact Contact us

Press releases

15th January
2018

Ipsen announces 13 posters and 1 oral presentation at the 2018 ASCO Gastrointestinal Symposium

download Download contact Contact us
16th January
2018

Ipsen and Exelixis announce phase 3 trial results of cabozantinib demonstrating significant overall survival benefit in patients with previously treated advanced hepatocellular carcinoma

download Download contact Contact us